IGC Pharma Inc (IGC)
NYSEAMERICAN: IGC · IEX Real-Time Price · USD
0.473
+0.013 (2.80%)
Jul 22, 2024, 11:25 AM EDT - Market open
IGC Pharma Employees
IGC Pharma had 67 employees as of March 31, 2024. The number of employees increased by 6 or 9.84% compared to the previous year.
Employees
67
Change (1Y)
6
Growth (1Y)
9.84%
Revenue / Employee
$20,075
Profits / Employee
-$194,030
Market Cap
35.90M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| DarioHealth | 294 |
| Achilles Therapeutics | 215 |
| Exagen | 179 |
| Retractable Technologies | 151 |
| Aadi Bioscience | 89 |
| IceCure Medical | 77 |
| Xilio Therapeutics | 73 |
| iCAD, Inc. | 69 |
IGC News
- 4 days ago - IGC Pharma Announces Equity Analyst Coverage by Alliance Global Partners (AGP) with a "Buy" Recommendation and $3.50 Price Target - Business Wire
- 13 days ago - Preclinical Analyses of TGR-63 Demonstrate Blood-Brain Barrier Permeability and Safety Profile - Business Wire
- 27 days ago - IGC Pharma's TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer's Disease - Business Wire
- 4 weeks ago - IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets - Business Wire
- 6 weeks ago - IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol - Business Wire
- 7 weeks ago - IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1 - Business Wire
- 2 months ago - IGC Pharma to Attend BIO International Convention 2024 - Business Wire
- 3 months ago - IGC-AD1's Interim Phase 2 Data Show a Reduction in Alzheimer's Agitation at Week Two - Business Wire